Stroke and Other Cerebrovascular Illnesses

The Mount Sinai Stroke Center is world-renowned for stroke research and treatment, in the areas of medical therapy for treating and preventing stroke, neurosurgical approaches to stroke prevention, and interventional neuroradiologic procedures for stroke patients.  The goal of stroke treatment at Mount Sinai is to improve the prevention of and recovery from a stroke.

Advances in Stroke Research

Our research focuses on the prevention of stroke, the treatment of acute stroke, and on ways to help patients recover optimally from stroke. We are one of the 25 regional coordinating centers in a network recently established by the National Institute of Neurological Disorders and Stroke (NINDS) to develop and perform clinical trials in the prevention and acute management of all forms of stroke, as well as in stroke rehabilitation. We are currently involved in the following research:

  • The underuse of stroke prevention therapies among minority populations is a major barrier in stroke treatment.  With the Department of Health Evidence and Policy and with funding from the Agency for Healthcare Research and Quality, the National Center on Minority Health and Health Disparities, and NINDS, we have conducted studies to determine the causes of.  We have also evaluated a program to address these causes in patients hospitalized at Mount Sinai and the surrounding communities.
  • In conjunction with the Department of Neurosurgery, we are conducting studies, funded by the National Institutes of Health, assessing the efficacy of thrombolytic medication to help dissolve blood clots in patients with intracerebral bleeding.
  • In collaboration with the Division of Neuroradiology, we are examining the application of new computed tomography (CT) scans and magnetic resonance imaging (MRI) techniques on patients with stroke to provide quicker and more accurate diagnostic and prognostic information.
  • We are involved in a multicenter cooperative study to determine the safety and efficacy of a high-dose statin medication as a neuroprotective agent in acute ischemic stroke.

Scientists involved: Bernadette Boden-Albala, Mandip Dhamoon, Roland Friedel, Carol R. Horowitz, Aaron P. Tansy, Stanley Tuhrim, Jesse Weinberger, Hongyan Zou

Advances in Patient Care

The Mount Sinai Health System offers advanced treatment for stroke based upon proven therapies for acute stroke and intracerebral hemorrhage. Learn more

Contact Us

Phone: 800-MD-SINAI (800-637-4624)
Phone: 212-241-7076
 
Mount Sinai Beth Israel
Phone: 212-844-8888
Fax: 212-844-8481

Mirken Department of Neurology
Phillips Ambulatory Care Center
10 Union Square East
Suite 5D
New York, NY 10003

Mount Sinai Roosevelt Stroke Center
Phone:  212-636-3236

Mount Sinai St. Luke's Stroke Center
Phone: 212-523-3144